Ken Fisher Fisher Asset Management
AUM
$252B
1-Year Return
19.67%
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
This Quarter Return
+12.6%
1 Year Return
+19.67%
3 Year Return
+104.4%
5 Year Return
+153.45%
10 Year Return
+356.28%
AUM
$252B
AUM Growth
+$20.9B
(+9%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-0.96%
Top 10 Holdings %
Top 10 Hldgs %
30.76%
Holding
1,093
New
94
Increased
337
Reduced
522
Closed
107
Top Buys
| 1 |
Royal Bank of Canada
RY
|
$696M |
| 2 |
Sony
SONY
|
$424M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$402M |
| 4 |
SAP
SAP
|
$354M |
| 5 |
Spotify
SPOT
|
$353M |
Top Sells
| 1 |
Oracle
ORCL
|
$1.91B |
| 2 |
NVIDIA
NVDA
|
$1.3B |
| 3 |
Salesforce
CRM
|
$1.04B |
| 4 |
Eli Lilly
LLY
|
$886M |
| 5 |
JPMorgan Chase
JPM
|
$868M |
Sector Composition
| 1 | Technology | 25.47% |
| 2 | Financials | 18.4% |
| 3 | Industrials | 9.35% |
| 4 | Healthcare | 9.18% |
| 5 | Communication Services | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
FNB Corp
FNB
$5.93B
| $12.9M | 0.01% |
886,493
+112,195
| +14% | +$1.64M |
|
377
Service Corp International
SCI
$10.8B
| $12.8M | 0.01% |
157,030
+25,274
| +19% | +$2.06M |
|
378
WSFS Financial
WSFS
$3.26B
| $12.6M | 0.01% |
229,921
+132
| +0.1% | +$7.26K |
|
379
Commerce Bancshares
CBSH
$8.08B
| $12.6M | 0.01% |
203,296
+24,318
| +14% | +$1.51M |
|
380
Sunstone Hotel Investors
SHO
$1.82B
| $12.6M | 0.01% |
1,451,274
-45,502
| -3% | -$395K |
|
381
Health Care Select Sector SPDR Fund
XLV
$34B
| $12.4M | ﹤0.01% |
92,267
+44,783
| +94% | +$6.04M |
|
382
Ameris Bancorp
ABCB
$5.08B
| $12.4M | ﹤0.01% |
191,121
-168
| -0.1% | -$10.9K |
|
383
PotlatchDeltic
PCH
$3.29B
| $12.3M | ﹤0.01% |
319,769
-1,360
| -0.4% | -$52.2K |
|
384
iShares 20+ Year Treasury Bond ETF
TLT
$48.8B
| $12.2M | ﹤0.01% |
138,125
-21,051
| -13% | -$1.86M |
|
385
ResMed
RMD
$40.3B
| $12.1M | ﹤0.01% |
46,773
+315
| +0.7% | +$81.3K |
|
386
Ligand Pharmaceuticals
LGND
$3.28B
| $12.1M | ﹤0.01% |
106,066
-1,440
| -1% | -$164K |
|
387
Cavco Industries
CVCO
$4.38B
| $12M | ﹤0.01% |
27,682
-44,797
| -62% | -$19.5M |
|
388
Synovus
SNV
$7.16B
| $12M | ﹤0.01% |
231,674
+66,576
| +40% | +$3.45M |
|
389
Oceaneering
OII
$2.42B
| $11.9M | ﹤0.01% |
573,330
+42,712
| +8% | +$885K |
|
|
CURB
390
Curbline Properties Corp.
CURB
$2.4B
| $11.8M | ﹤0.01% |
517,466
-47,759
| -8% | -$1.09M |
|
391
Kaiser Aluminum
KALU
$1.24B
| $11.8M | ﹤0.01% |
147,475
+54
| +0% | +$4.32K |
|
392
Vertex Pharmaceuticals
VRTX
$101B
| $11.5M | ﹤0.01% |
25,755
-4,914
| -16% | -$2.19M |
|
393
Virtus Investment Partners
VRTS
$1.31B
| $11.4M | ﹤0.01% |
62,790
-4,181
| -6% | -$758K |
|
|
PPBI
394
DELISTED
Pacific Premier Bancorp
PPBI
| $11.3M | ﹤0.01% |
537,005
+5
| +0% | +$105 |
|
395
Atlantic Union Bankshares
AUB
$5.08B
| $11.3M | ﹤0.01% |
361,633
+1,353
| +0.4% | +$42.3K |
|
396
Lantheus
LNTH
$3.73B
| $11.3M | ﹤0.01% |
138,155
-4,393
| -3% | -$360K |
|
397
Southern Company
SO
$101B
| $11.2M | ﹤0.01% |
122,408
+6,129
| +5% | +$563K |
|
398
Credicorp
BAP
$20.5B
| $11.1M | ﹤0.01% |
49,621
-5,082
| -9% | -$1.14M |
|
399
TechnipFMC
FTI
$16.1B
| $11.1M | ﹤0.01% |
320,970
-88,353
| -22% | -$3.04M |
|
400
Neurocrine Biosciences
NBIX
$14.4B
| $11M | ﹤0.01% |
87,540
-7,717
| -8% | -$970K |
|